What is it about?
GFAP is a promising biomarker of brain injury and neurological disease. We establish a reference interval in Danish children from 0.4-17.9 years. It shows a strong age-dependency with decreasing levels from infancy to adolescence.
Featured Image
Read the Original
This page is a summary of: Serum GFAP – pediatric reference interval in a cohort of Danish children, Clinical Chemistry and Laboratory Medicine (CCLM), May 2023, De Gruyter,
DOI: 10.1515/cclm-2023-0280.
You can read the full text:
Contributors
Be the first to contribute to this page
